Bempedoic Acid (ETC-1002): A Randomized, Double-Blind, Placebo-Controlled Study

Do you have, or are you at high risk for, cardiovascular disease (CVD, also known as heart disease)?

Are you unable to take statin medications due to side effects?

You may be eligible for a clinical research study being conducted to test the safety and effectiveness of an investigational medication that may help to reduce the occurrence of major CVD events, such as heart attacks and strokes, for patients with, or at risk for CVD, who are also statin intolerant.

To qualify you must:

  • Be at least 18 years of age
  • Have a history of, or are at high risk for, CVD
  • Be statin intolerant (have not been able to tolerate two or more statins)
  • Meet additional study criteria

Qualified participants will receive all study medication and study-related care from a dedicated team of medical staff at no cost.

Health insurance is not required to participate.

To find out more, and to see if you qualify, contact:

Center for Cardiovascular Disease Prevention
Phone: (713) 798-3330


Study Coordinator ccdp@bcm.eduPhone 1: (713) 798-3330
IRB: h-40735




Mar 29, 2017